Skip to contentC
CareDx, Inc.
C
CDNACareDx, Inc. Q2 2024 · 10-Q
Revenue$92.27M$92.27M+31.3% vs Q2 2023 Net Income-$4.62M-$4.62MN/M vs Q2 2023 EPS Diluted-$0.09-$0.09N/M vs Q2 2023 Operating Income-$7,327,000N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
CareDx, Inc. · CIK 1217234 · Engraved from SEC EDGAR
derived
Margins · derivedOperating margin-7.9%+31.4 pt vs Q2 2023
Net margin-5.0%+30.5 pt vs Q2 2023
ended Jun 30, 2024 · filed Jul 31, 2024 · 31 d after period end